Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Net Income towards Common Stockholders (2016 - 2025)

Conmed (CNMD) has disclosed Net Income towards Common Stockholders for 11 consecutive years, with $135.5 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Net Income towards Common Stockholders fell 4.55% year-over-year to $135.5 million, compared with a TTM value of $135.5 million through Sep 2021, down 70.97%, and an annual FY2025 reading of $47.1 million, down 64.47% over the prior year.
  • Net Income towards Common Stockholders was $135.5 million for Q4 2020 at Conmed, up from $133.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $152.4 million in Q4 2017 and bottomed at $71.9 million in Q2 2020.
  • Average Net Income towards Common Stockholders over 5 years is $115.6 million, with a median of $113.4 million recorded in 2018.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 45.14% in 2017, then crashed 45.17% in 2020.
  • Year by year, Net Income towards Common Stockholders stood at $105.0 million in 2016, then skyrocketed by 45.14% to $152.4 million in 2017, then dropped by 12.93% to $132.7 million in 2018, then increased by 7.03% to $142.0 million in 2019, then decreased by 4.55% to $135.5 million in 2020.
  • Business Quant data shows Net Income towards Common Stockholders for CNMD at $135.5 million in Q4 2020, $133.7 million in Q3 2020, and $71.9 million in Q2 2020.